What Is Tirzepatide? How It Works, FDA Status & Who Qualifies

If you've been researching weight loss medications, you've likely come across tirzepatide. Originally developed for type 2 diabetes, tirzepatide has become one of the most effective FDA-approved treatments for chronic weight management. Clinical trials show patients losing up to 22.5% of their body weight — results previously only achievable through surgery.

But what exactly is tirzepatide, how does it work, and could it be right for you? Here's everything you need to know.

How Tirzepatide Works

Tirzepatide belongs to a new class of medications called dual GIP/GLP-1 receptor agonists. Unlike older weight loss drugs that target a single pathway, tirzepatide activates two hormones simultaneously:

• GLP-1 (glucagon-like peptide-1) — Slows gastric emptying, reduces appetite, and signals fullness to your brain. This is the same pathway targeted by semaglutide (Wegovy/Ozempic).
• GIP (glucose-dependent insulinotropic polypeptide) — Enhances insulin sensitivity, improves fat metabolism, and amplifies the appetite-suppressing effects of GLP-1.

By targeting both receptors, tirzepatide delivers stronger appetite reduction and more consistent weight loss than GLP-1-only medications. Most patients report that food simply becomes less interesting — cravings for high-calorie foods diminish significantly within the first few weeks.

FDA Approval Status

Tirzepatide has received FDA approval under two brand names:

• Mounjaro — Approved in May 2022 for type 2 diabetes management
• Zepbound — Approved in November 2023 specifically for chronic weight management in adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related condition

The approval was based on the landmark SURMOUNT clinical trial program, which demonstrated:

• Average weight loss of 18–22.5% of body weight over 72 weeks
• Over 60% of participants lost more than 20% of their body weight at the highest dose
• Significant improvements in blood pressure, cholesterol, and blood sugar levels

Who Qualifies for Tirzepatide?

You may be a candidate for tirzepatide if you meet the following criteria:

• BMI of 30 or higher (obesity), OR
• BMI of 27 or higher with at least one weight-related health condition such as high blood pressure, type 2 diabetes, high cholesterol, or sleep apnea
• You are 18 years or older
• Previous attempts at diet and exercise alone have not achieved lasting results

Tirzepatide is not recommended for individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). A licensed clinician will review your full medical history before prescribing.

What to Expect: Dosing & Timeline

Tirzepatide is administered as a once-weekly subcutaneous injection using a pre-filled pen. The dosing schedule typically follows a gradual escalation:

• Weeks 1–4: 2.5 mg (starting dose to minimize side effects)
• Weeks 5–8: 5 mg
• Weeks 9–12: 7.5 mg
• Week 13+: 10 mg, with potential increases to 12.5 mg or 15 mg based on response

Most patients begin noticing appetite changes within the first 1–2 weeks. Meaningful weight loss typically becomes visible by weeks 4–8, with the most dramatic results occurring between months 3–6.

Common Side Effects

The most frequently reported side effects are gastrointestinal and usually subside as your body adjusts:

• Nausea (most common, typically resolves within 2–3 weeks)
• Diarrhea or constipation
• Decreased appetite (often considered a benefit)
• Injection site reactions (mild redness or irritation)

The gradual dose escalation protocol is specifically designed to minimize these effects. Your clinician will adjust your dosage based on tolerability.

How to Get Started with Tirzepatide Through LAVIA

LAVIA makes accessing tirzepatide straightforward. Our telehealth platform connects you with licensed clinicians who specialize in GLP-1 weight loss treatments. Here's how it works:

1. Complete your online qualification — A brief health questionnaire takes about 5 minutes
2. Clinician review — A licensed provider reviews your medical history and determines if tirzepatide is right for you
3. Medication shipped to your door — If approved, your prescription is filled and delivered within 48 hours
4. Ongoing support — Weekly check-ins and dose adjustments to optimize your results